- Investing Ideas
- U.S. Pharmaceuticals & Biotech Breakout Stocks
U.S. Pharmaceuticals & Biotech Breakout Stocks
Results
17
Stocks where the price continues to rise after more than a year of consistent gains.
17 companies
10x Genomics
Market Cap: US$7.5b
Develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific.
TXG
US$58.15
7D
27.5%
1Y
339.2%
AbCellera Biologics
Market Cap: US$3.4b
Engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States.
ABCL
US$10.97
7D
68.0%
1Y
143.8%
Omeros
Market Cap: US$992.3m
A clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases.
OMER
US$17.35
7D
31.9%
1Y
321.1%
OmniAb
Market Cap: US$497.2m
A biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.
OABI
US$3.43
7D
53.1%
1Y
71.5%
AVITA Medical
Market Cap: US$251.1m
Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.
RCEL
US$8.01
7D
68.6%
1Y
38.1%
PepGen
Market Cap: US$200.9m
A clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States.
PEPG
US$2.98
7D
23.7%
1Y
131.0%
Gain Therapeutics
Market Cap: US$90.4m
A biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas in Switzerland, Spain, the United States, and Australia.
GANX
US$2.17
7D
21.6%
1Y
40.6%
AquaBounty Technologies
Market Cap: US$7.1m
Operates as a land-based aquaculture company.
AQB
US$1.50
7D
40.2%
1Y
102.7%
Enzolytics
Market Cap: US$2.7m
A drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases.
ENZC
US$0.0007
7D
75.0%
1Y
16.7%
International Stem Cell
Market Cap: US$2.6m
A clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally.
ISCO
US$0.31
7D
24.0%
1Y
106.0%
Cannabis Global
Market Cap: US$829.0k
Focuses on the creating and commercialization of engineered technologies to deliver hemp extracts and cannabinoids to the human body.
CBGL
US$0.0001
7D
9,900.0%
1Y
9,900.0%
PAO Group
Market Cap: US$382.0k
Focuses on alternative patient care treatments.
PAOG
US$0.0003
7D
50.0%
1Y
29,900.0%
Medicine Man Technologies
Market Cap: US$171.2k
Medicine Man Technologies, Inc., doing business as Schwazze, engages in the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis related products in Colorado and New Mexico.
SHWZ
US$0.002
7D
199,900.0%
1Y
100.0%
Parallel Industries
Market Cap: US$134.5k
Does not have significant operations.
EAPH
US$0.0001
7D
9,900.0%
1Y
9,900.0%
U.S. Stem Cell
Market Cap: US$66.2k
Engages in the research, development, and commercialization of stem cell and regenerative treatments in the United States and internationally.
USRM
US$0.0001
7D
900.0%
1Y
9,900.0%
BioELife
Market Cap: US$940.0
Operates in cannabinoid market.
LITH
US$0.0001
7D
9,900.0%
1Y
0%
Hero Technologies
Market Cap: US$563.0
Operates as an early-stage cannabis company.
HENC
US$0.0001
7D
9,900.0%
1Y
0%